{"id":"https://openalex.org/W2264328252","doi":null,"title":"Abstract 15652: Comparison of the Novel Peroxisome Proliferator-Activated Receptor Alpha Agonist K-877 and Fenofibrate on High-Density Lipoprotein Subclass Distribution Determined by High-Performance Liquid Chromatography in Patients With Dyslipidemia","display_name":"Abstract 15652: Comparison of the Novel Peroxisome Proliferator-Activated Receptor Alpha Agonist K-877 and Fenofibrate on High-Density Lipoprotein Subclass Distribution Determined by High-Performance Liquid Chromatography in Patients With Dyslipidemia","alternate_titles":[],"publication_year":2013,"publication_date":"2013-11-26","ids":{"openalex":"https://openalex.org/W2264328252","mag":"2264328252"},"language":"en","primary_location":{"id":"mag:2264328252","doi":null,"is_oa":false,"landing_page_url":"https://www.ahajournals.org/doi/10.1161/circ.128.suppl_22.A15652","pdf_url":null,"source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Circulation","raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W2264328252"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089216722","display_name":"Shizuya Yamashita","orcid":"https://orcid.org/0000-0001-6645-4185","observed_orcids":["https://orcid.org/0000-0001-6645-4185"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shizuya Yamashita","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6645-4185","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058350680","display_name":"Shun Ishibashi","orcid":"https://orcid.org/0000-0002-1063-1979","observed_orcids":["https://orcid.org/0000-0002-1063-1979"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shun Ishibashi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1063-1979","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076061467","display_name":"Hidenori Arai","orcid":"https://orcid.org/0000-0002-9000-6849","observed_orcids":["https://orcid.org/0000-0002-9000-6849"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hidenori Arai","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9000-6849","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067248419","display_name":"Eiichi Araki","orcid":"https://orcid.org/0000-0002-4064-7525","observed_orcids":["https://orcid.org/0000-0002-4064-7525"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eiichi Araki","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4064-7525","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079640536","display_name":"Koutaro Yokote","orcid":"https://orcid.org/0000-0003-3033-4813","observed_orcids":["https://orcid.org/0000-0003-3033-4813"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Koutaro Yokote","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3033-4813","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5107007603","display_name":"Tatsuhiko Kodama","orcid":"https://orcid.org/0000-0003-3747-7956","observed_orcids":["https://orcid.org/0000-0003-3747-7956"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tatsuhiko Kodama","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"128","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.4790000021457672,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.4790000021457672,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.28780001401901245,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.11599999666213989,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fenofibrate","display_name":"fenofibrate","score":0.9470000267028809},{"id":"https://openalex.org/keywords/hdl-subfractions","display_name":"HDL subfractions","score":0.8299999833106995},{"id":"https://openalex.org/keywords/hdl3","display_name":"HDL3","score":0.8999999761581421},{"id":"https://openalex.org/keywords/hdl2-cholesterol","display_name":"HDL2","score":0.984000027179718},{"id":"https://openalex.org/keywords/dyslipidemia","display_name":"dyslipidemia","score":0.9169999957084656},{"id":"https://openalex.org/keywords/reverse-cholesterol-transport","display_name":"reverse cholesterol transport","score":0.8659999966621399}],"concepts":[{"id":"https://openalex.org/C2778110834","wikidata":"https://www.wikidata.org/wiki/Q419724","display_name":"Fenofibrate","level":2,"score":0.9564723968505859},{"id":"https://openalex.org/C2778096610","wikidata":"https://www.wikidata.org/wiki/Q1476525","display_name":"Dyslipidemia","level":3,"score":0.8149666786193848},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.805600643157959},{"id":"https://openalex.org/C2776194381","wikidata":"https://www.wikidata.org/wiki/Q3965271","display_name":"Subclass","level":3,"score":0.7093459963798523},{"id":"https://openalex.org/C188413054","wikidata":"https://www.wikidata.org/wiki/Q18030677","display_name":"Peroxisome proliferator-activated receptor alpha","level":5,"score":0.6710833311080933},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.5844464898109436},{"id":"https://openalex.org/C64943373","wikidata":"https://www.wikidata.org/wiki/Q2651003","display_name":"Alpha (finance)","level":4,"score":0.5703603029251099},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5181166529655457},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5058276653289795},{"id":"https://openalex.org/C2780072125","wikidata":"https://www.wikidata.org/wiki/Q28350","display_name":"Lipoprotein","level":3,"score":0.48317447304725647},{"id":"https://openalex.org/C187345961","wikidata":"https://www.wikidata.org/wiki/Q419629","display_name":"Peroxisome proliferator-activated receptor","level":3,"score":0.44325655698776245},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.42355281114578247},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.35981130599975586},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.27739405632019043},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2639935612678528},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.1028490662574768},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.10170018672943115},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.09670686721801758},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.08490970730781555},{"id":"https://openalex.org/C63932345","wikidata":"https://www.wikidata.org/wiki/Q422500","display_name":"Nuclear receptor","level":4,"score":0.0786166787147522},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.0646677017211914},{"id":"https://openalex.org/C2775944032","wikidata":"https://www.wikidata.org/wiki/Q22907659","display_name":"Patient satisfaction","level":2,"score":0.0},{"id":"https://openalex.org/C86339819","wikidata":"https://www.wikidata.org/wiki/Q407384","display_name":"Transcription factor","level":3,"score":0.0},{"id":"https://openalex.org/C49453240","wikidata":"https://www.wikidata.org/wiki/Q1592163","display_name":"Construct validity","level":3,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2264328252","doi":null,"is_oa":false,"landing_page_url":"https://www.ahajournals.org/doi/10.1161/circ.128.suppl_22.A15652","pdf_url":null,"source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Circulation","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2280192011","https://openalex.org/W2123463228","https://openalex.org/W2765940957","https://openalex.org/W2155748262","https://openalex.org/W1964308155","https://openalex.org/W2026792133","https://openalex.org/W2765263832","https://openalex.org/W2013356245","https://openalex.org/W2145666707","https://openalex.org/W2051425317"],"abstract_inverted_index":{"Introduction:":[0],"HDL":[1,13,16,23],"is":[2],"a":[3],"class":[4],"of":[5],"structurally":[6],"and":[7],"functionally":[8],"heterogeneous":[9],"particles.":[10],"Among":[11],"the":[12],"particles,":[14],"small":[15],"(HDL3)":[17],"are":[18],"more":[19],"functional":[20],"than":[21],"large":[22],"(HDL2)":[24],"in":[25],"reverse":[26],"cholesterol":[27],"tra...":[28]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2264328252","counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
